Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
27.40
-1.44 (-4.99%)
Sep 11, 2026, 4:08 PM HKT

HKG:3378 Statistics

Total Valuation

HKG:3378 has a market cap or net worth of HKD 3.73 billion. The enterprise value is 3.25 billion.

Market Cap3.73B
Enterprise Value 3.25B

Important Dates

The last earnings date was Monday, August 17, 2026.

Earnings Date Aug 17, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:3378 has 136.22 million shares outstanding. The number of shares has increased by 8.28% in one year.

Current Share Class 136.22M
Shares Outstanding 136.22M
Shares Change (YoY) +8.28%
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.43%
Owned by Institutions (%) 2.32%
Float 19.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 44,287.77
PB Ratio 4.71
P/TBV Ratio 5.11
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.58, with a Debt / Equity ratio of 0.11.

Current Ratio 18.58
Quick Ratio 16.57
Debt / Equity 0.11
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -19.87

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -17.30%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 1,405
Profits Per Employee -2.53M
Employee Count60
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -1.04M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 28.99
200-Day Moving Average n/a
Relative Strength Index (RSI) 38.34
Average Volume (20 Days) 11,653

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:3378 had revenue of HKD 84,276 and -151.76 million in losses. Loss per share was -1.19.

Revenue84,276
Gross Profit 84,276
Operating Income -163.32M
Pretax Income -152.36M
Net Income -151.76M
EBITDA -159.47M
EBIT -163.32M
Loss Per Share -1.19
Full Income Statement

Balance Sheet

The company has 628.35 million in cash and 85.13 million in debt, with a net cash position of 543.22 million or 3.99 per share.

Cash & Cash Equivalents 628.35M
Total Debt 85.13M
Net Cash 543.22M
Net Cash Per Share 3.99
Equity (Book Value) 792.00M
Book Value Per Share 5.37
Working Capital 666.89M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 3.90M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -193,792.89%
Pretax Margin -180,792.82%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:3378 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.28%
Shareholder Yield -8.28%
Earnings Yield -4.07%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a